Mycobacterium tuberculosis Complex Genotype Diversity and Drug Resistance Profiles in a Pediatric Population in Mexico

Table 1

Characteristics of M. tuberculosis drug resistance to first line antituberculosis drugs.

Number of drugs	Number of isolates	Resistance to antituberculosis drugs (no and %)
		INH	STM	RMP	PZA	EMB
1	8	5 (23.8)	3 (21.2)	—	—	—
2	6	6 (28.5)	2 (18.1)	2 (20.0)	1 (12.5)	1 (11.1)
3	5	5 (23.8)	2 (18.1)	3 (30.0)	2 (25.0)	3 (33.3)
4	1	1 (4.7)	—	1 (10.0)	1 (12.5)	1 (11.1)
5	4	4 (19.0)	4 (36.3)	4 (40.0)	4 (50.0)	4 (44.1)
Global resistance	24	21 (23.3)	11 (12.2)	10 (11.1)	8 (8.8)	9 (10.0)

INH: Isoniazid, STM: Streptomycin, RMP: Rifampicin, PZA: Pyrazinamide, EMB: Ethambutol.